MARKET

HQL

HQL

Tekla Life Sciences Investors
NYSE

Real-time Quotes | Provided by Morningstar

14.75
+0.33
+2.29%
Closed 16:00 05/27 EDT
OPEN
14.45
PREV CLOSE
14.42
HIGH
14.82
LOW
14.43
VOLUME
63.87K
TURNOVER
479.85K
52 WEEK HIGH
22.70
52 WEEK LOW
13.53
TOTAL ASSET
398.64M
YTD YIELD
5.41%
1D
5D
1M
3M
1Y
5Y
Tekla Life Sciences's Ex-Dividend Date Is Thursday, Here's What You Need To Know
Wednesday marks the last chance for investors to receive the next dividend payout from Tekla Life Sciences (NYSE:HQL).
Benzinga · 4d ago
Office And Retail Regain Sparkle in South Africa, Investec Says
Bloomberg · 05/18 14:25
Tekla Life Sciences cuts dividend by 10% to $0.35
Tekla Life Sciences (NYSE:HQL) declares $0.35/share quarterly dividend, -10.3% decrease from prior dividend of $0.39. Forward yield 9.43% Payable June 30; for shareholders of record May 27; ex-div May 26.
Seekingalpha · 05/17 15:47
--Tekla Life Sciences Cuts Quarterly Dividend to $0.35 a Share From $0.39, Payable June 30 to Shareholders as of May 27
MT Newswires · 05/17 12:59
Fed’s Unwind Plan Leaves Money Markets Starved for Supply
Bloomberg · 04/06 20:13
Sector Update: Financial
MT Newswires · 03/22 15:44
Tekla Capital's funds extend buyback through 2023
Tekla Capital's managed funds have announced one-year extension of their stock buyback program to now expire on June. 14, 2023. It comes from Tekla Healthcare Opportunities Fund (THQ +0.6%), Tekla
Seekingalpha · 03/22 14:37
Muni Strategists See Average of $470 Billion of Supply in 2022
Bloomberg · 11/24/2021 17:00
More
No Data
Learn about the latest financial forecast of HQL. Analyze the recent business situations of Tekla Life Sciences Investors through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
No Data
  • Performance
  • Asset Allocation
  • Dividend History
Period
Return
Rank in Cat
1-Day
-21.3300%
--
1-Month
-9.7071%
--
3-Month
-5.0632%
--
6-Month
-18.8725%
--
1-Year
-17.7329%
--
3-Year
16.0779%
--
5-Year
17.8982%
--
10-Year
159.6719%
--
No Data
No Data
No Data
Profile
Fund Name
Tekla Life Sciences Investors
Inception Date
1992-05-08
Advisor Company
Tekla Capital Management LLC
Custodian
State Street Bank and Trust Company
Manager
Team Managed